Internal Medicine, Medical Oncology · Baltimore, MD
NPI
1174558126
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
600 N Wolfe St
Baltimore, MD, 21287
Phone (410) 955-8964
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
517 services
Medicare patients, 2024
172
Average age 72
Drug cost, 2024
$2.2M
289 prescriptions
Company payments, 2025
$20K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bruce Smith was code 99232 (hospital e&m - subsequent), 216 times for 35 patients. In total Bruce Smith billed 517 services in 12 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 216 | 35 | $64.15 | $14K |
| 99215 Office E&M - Established | Facility | 147 | 61 | $106.21 | $16K |
| 85097 Test - Miscellaneous | Facility | 54 | 51 | $37.96 | $2,050 |
| 99223 Hospital E&M - Initial | Facility | 25 | 22 | $137.05 | $3,426 |
| 99214 Office E&M - Established | Facility | 20 | 19 | $75.28 | $1,506 |
| 99215 Office E&M - Established | Office | 15 | 12 | $144.15 | $2,162 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 12 | 12 | $13.41 | $161 |
By year: 2022 $44K for 441 services; 2023 $37K for 442 services; 2024 $41K for 517 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bruce Smith prescribed most often to Medicare patients was Sprycel (Dasatinib), with 81 prescriptions and refills. In total Bruce Smith wrote 289 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sprycel Dasatinib | 81 | 81 | 11 | $734K |
| Imatinib Mesylate Generic | 51 | 59 | Under 11 | $77K |
| Allopurinol Generic | 22 | 42 | Under 11 | $202 |
| Dasatinib Generic | 15 | 15 | Under 11 | $131K |
| Venclexta Venetoclax | 15 | 16 | Under 11 | $72K |
| Tasigna Nilotinib Hcl | 12 | 12 | Under 11 | $213K |
| Tibsovo Ivosidenib | 11 | 11 | Under 11 | $354K |
Brand drugs: 151 claims; generic drugs: 138 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bruce Smith $20K ($15K in general payments such as food, travel and fees and $5,101 for research) from 3 companies. The largest payer was Servier Pharmaceuticals LLC with $17K.
| Company | Payments | Amount |
|---|---|---|
| Servier Pharmaceuticals LLC | 20 | $17K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $3,300 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.